urotensin-II
SMILES | None |
InChIKey | None |
Sequence | QHGTAPECFWKYCI |
Chemical properties
Hydrogen bond acceptors | None |
Hydrogen bond donors | None |
Rotatable bonds | None |
Molecular weight (Da) |
Drug properties
Molecular type | Peptide |
Endogenous/Surrogate | Endogenous |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
LPA2 | LPAR2 | Human | Lysophospholipid (LPA) | A | pKi | 5.25 | 5.25 | 5.25 | Guide to Pharmacology |
LPA3 | LPAR3 | Human | Lysophospholipid (LPA) | A | pKi | 6.44 | 6.44 | 6.44 | Guide to Pharmacology |
LPA3 | LPAR3 | Human | Lysophospholipid (LPA) | A | pKi | 6.83 | 6.83 | 6.83 | ChEMBL |
LPA1 | LPAR1 | Human | Lysophospholipid (LPA) | A | pKi | 6.37 | 6.37 | 6.37 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
LPA1 | LPAR1 | Mouse | Lysophospholipid (LPA) | A | pIC50 | 6.6 | 6.75 | 6.9 | Guide to Pharmacology |
LPA2 | LPAR2 | Human | Lysophospholipid (LPA) | A | pIC50 | 5.92 | 5.92 | 5.92 | ChEMBL |
LPA3 | LPAR3 | Human | Lysophospholipid (LPA) | A | pIC50 | 5.8 | 6.16 | 6.52 | ChEMBL |
LPA1 | LPAR1 | Human | Lysophospholipid (LPA) | A | pIC50 | 6.1 | 6.53 | 7.34 | ChEMBL |
LPA1 | LPAR1 | Rat | Lysophospholipid (LPA) | A | pIC50 | 6.8 | 6.8 | 6.8 | ChEMBL |